Status:
COMPLETED
Optimal Application Dose of Superficial Hyperthermia
Lead Sponsor:
Universitätsmedizin Mannheim
Conditions:
Tumors
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Hyperthermia - a warming of the tumor at 42-43 ° C - in combination with radiation and / or chemotherapy is a proven method of treatment for malignant tumors. The amplification of the effect of radiot...
Eligibility Criteria
Inclusion
- Surficial tumors (\< 3-4 cm)
- ≥ 18 years
- Karnofsky Index \> 60
- No other treatment in between 30 d, applicable radiation dose min.30 Gy
- Cumulative equivalent minutes 42°C T75
Exclusion
- Pregnancy
- Pace maker
- Metal implants
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00766233
Start Date
January 1 2008
End Date
February 1 2016
Last Update
September 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiotherapy University Hospital Mannheim
Mannheim, Germany, 68167